6.88
price up icon2.99%   0.20
after-market アフターアワーズ: 6.89 0.010 +0.15%
loading
前日終値:
$6.68
開ける:
$6.92
24時間の取引高:
902.64K
Relative Volume:
0.32
時価総額:
$745.75M
収益:
$42.51M
当期純損益:
$-116.49M
株価収益率:
-6.1429
EPS:
-1.12
ネットキャッシュフロー:
$-120.82M
1週間 パフォーマンス:
+8.35%
1か月 パフォーマンス:
+29.32%
6か月 パフォーマンス:
+125.57%
1年 パフォーマンス:
-29.44%
1日の値動き範囲:
Value
$6.85
$7.09
1週間の範囲:
Value
$6.36
$7.14
52週間の値動き範囲:
Value
$1.03
$12.02

Tango Therapeutics Inc Stock (TNGX) Company Profile

Name
名前
Tango Therapeutics Inc
Name
セクター
Healthcare (1163)
Name
電話
(857) 320-4900
Name
住所
201 BROOKLINE AVENUE, BOSTON
Name
職員
155
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
TNGX's Discussions on Twitter

TNGX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TNGX
Tango Therapeutics Inc
6.88 724.07M 42.51M -116.49M -120.82M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-07-17 開始されました Jefferies Buy
2024-04-04 開始されました Cantor Fitzgerald Overweight
2024-02-12 開始されました Piper Sandler Overweight
2023-12-08 開始されました B. Riley Securities Buy
2022-10-20 アップグレード H.C. Wainwright Neutral → Buy
2021-09-20 開始されました SVB Leerink Outperform
すべてを表示

Tango Therapeutics Inc (TNGX) 最新ニュース

pulisher
09:30 AM

Is Tango Therapeutics Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional

09:30 AM
pulisher
Jul 22, 2025

What analysts say about Tango Therapeutics Inc. stockTremendous growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Tango Therapeutics Inc. stock priceFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Will Tango Therapeutics Inc. stock benefit from interest rate changesMarket Timing Advice - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Tango Therapeutics Inc. Stock Analysis and ForecastAccelerated financial growth - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

How high can Tango Therapeutics Inc. stock price go in 2025Daily Volume Leaders - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Can Tango Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Tango Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth Strategies - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Tango Therapeutics (TNGX) Soars 5.96% on Strong Q2 Earnings - AInvest

Jul 09, 2025
pulisher
Jul 06, 2025

Tango Therapeutics’ SWOT analysis: biotech stock’s potential in precision cancer therapies - Investing.com

Jul 06, 2025
pulisher
Jul 06, 2025

Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - MSN

Jul 06, 2025
pulisher
Jul 03, 2025

HC Wainwright Issues Optimistic Forecast for TNGX Earnings - Defense World

Jul 03, 2025
pulisher
Jun 30, 2025

Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 3000 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

H.C. Wainwright reiterates Buy rating on Tango Therapeutics stock - Investing.com

Jun 30, 2025
pulisher
Jun 27, 2025

Tango Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire

Jun 27, 2025
pulisher
Jun 27, 2025

Tango Therapeutics Launches Groundbreaking Trial for Advanced Pancreatic and Lung Cancer Treatment - Stock Titan

Jun 27, 2025
pulisher
Jun 25, 2025

Exchange Traded Concepts LLC Purchases 47,901 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Jun 25, 2025
pulisher
Jun 21, 2025

Tango Therapeutics' Mysterious 7.5% Spike: What’s Behind the Move? - AInvest

Jun 21, 2025
pulisher
Jun 16, 2025

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jun 16, 2025
pulisher
Jun 14, 2025

Tango Therapeutics’ SWOT analysis: stock poised for growth amid clinical trials - Investing.com

Jun 14, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 23,166 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

B. Riley Increases Earnings Estimates for Tango Therapeutics - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

What is B. Riley’s Forecast for TNGX Q2 Earnings? - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Makes New $40,000 Investment in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Takes Position in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Stock Holdings Increased by Bank of America Corp DE - Defense World

Jun 09, 2025

Tango Therapeutics Inc (TNGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
大文字化:     |  ボリューム (24 時間):